A new Endocrine Society guideline details how to treat adult patients with hypercalcemia of malignancy, the most common metabolic cancer complication. Despite its high morbidity and mortality rates, this is the very first guideline that directly addresses this condition and confirms the efficacy of denosumab and bisphosphonates. Adults with hypercalcemia of malignancy should be treated […]
Endocrine Society Publishes First Hypercalcemia of Malignancy Guideline
Join the Global Movement Advancing Endocrine Science and Medicine
Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.